Neurocrine Biosciences
NBIX
#1201
Rank
A$25.21 B
Marketcap
$249.03
Share price
-0.96%
Change (1 day)
14.59%
Change (1 year)
Neurocrine Biosciences is an American biopharmaceutical company that develops treatments for neurological and endocrine-related diseases and disorders.

We have found no dividend yield history for this company